✦ LIBER ✦

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

✍ Scribed by Oliver Sartor; Martin K Dineen; Ramon Perez-Marreno; Franklin M Chu; Graham J Carron; Robert C Tyler

Book ID: 117265235
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 114 KB
Volume: 62
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(03)00330-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 12-Month Clinical Study of LA-2585 (45

A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer

✍ Crawford, E. David; Sartor, Oliver; Chu, Franklin; Perez, Ramon; Karlin, Gary; G 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

A Clinical Study Of 22.5 mg. La-2550: A

A Clinical Study Of 22.5 mg. La-2550: A New Subcutaneous Depot Delivery System For Leuprolide Acetate For The Treatment Of Prostate Cancer

✍ Chu, Franklin M.; Jayson, Maury; Dineen, Martin K.; Perez, Ramon; Harkaway, Rich 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 161 KB